Clinical Trials in Massachusetts

Showing 10021-10040 of 17,868 trials

A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults

NCT04584710

The proposed trial will obtain preliminary data on the feasibility of studying RTB101 as compared to placebo for COVID-19 post-exposure prophylaxis in adults age ≥ 65 years to inform the design of a subsequent pivotal trial.

Covid19

Restorbio Inc.60 participantsStarted Oct 2020

Farmington, Connecticut, United States • Roslindale, Massachusetts, United States

TERMINATEDNA25 miles

MINDFUL-PC for Portuguese Speakers Pilot Study 2020

NCT04268355

The study evaluates the effects of the Mindfulness Training for Primary Care (MTPC) Portuguese-adapted version on heart rate variability during a demanding cognitive task. The study also evaluates the effects on mental health, quality of life, self-regulation and behavior outcomes. The study will also complete the MTPC cultural adaptation process for Brazilian culture.

DepressionAnxiety DisordersStress Related Disorder+2 more

Cambridge Health Alliance15 participantsStarted Jan 2020

Somerville, Massachusetts, United States

COMPLETEDPhase 226 miles

Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas

NCT01767792

To determine the hearing response rate at 24 weeks after treatment with bevacizumab for symptomatic vestibular schwannomas (VS) in children and young adults with Neurofibromatosis Type 2 (NF 2).

Neurofibromatosis Type 2Progressive Vestibular Schwannomas

University of Alabama at Birmingham22 participantsStarted May 2013

Los Angeles, California, United States • Washington D.C., District of Columbia, United States • Atlanta, Georgia, United States +9 more locations

A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults

MINDFUL-PC for Portuguese Speakers Pilot Study 2020

Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas

Find Trials by Condition in Massachusetts

Alcohol and Sex Risk Intervention for MSM Supplement

Randomized Trial to Assess PO Versus IV Antibiotics

The ICON Study: Outcomes After FMT for Patients With IBD and CDI

Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD).

Study of MEDI4736 Monotherapy and in Combination With Tremelimumab Versus Standard of Care Therapy in Patients With Head and Neck Cancer

Comparative Study of Intermittent Catheters and Occurrence of Urinary Tract Infections

Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects With Sickle Cell Disease

A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk

Phase 2 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes

Study to Evaluate Efficacy and Safety of E-101 Solution for Preventing Surgical Site Infections After Colorectal Surgery

The Altis® Single Incision Sling System for Female Stress Urinary Incontinence Study

A-Health RCT: Effects of Participatory Art-based Activity on Health of Older Community Dwellers

Lyrica Dose Response Study With Restless Legs Syndrome (RLS) Patients

Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures

P4 (Pregabalin for Peripheral Posttraumatic Pain)

Efficacy and Safety Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis Patients

Safety, Tolerability and Efficacy of Rapid Optimization, Helped by NT-proBNP testinG, of Heart Failure Therapies